#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bulbospinal muscular atrophy congenital Extranodal marginal zone B-cell lymphoma (MALT type) Pulmonary fibrosis Leukodystrophy Hereditary spastic paraplegia Neuroendocrine tumour of the lung Alveolar rhabdomyosarcoma Salivary gland cancer Glioblastoma Huntington's disease Wiskott-Aldrich syndrome Cataract Synovial sarcoma Sickle cell disease Ewing's sarcoma recurrent More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV Leiomyosarcoma metastatic – Treatment Rhabdomyosarcoma recurrent – Treatment Myxofibrosarcoma Arterial tortuosity syndrome – Basic Information Pemphigoid IgA nephropathy – Trials in Disease Malignant fibrous histiocytoma – Basic Information Andersen-Tawil syndrome – Basic Information Bronchopulmonary dysplasia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mva-209-Fsp-B1 Temocillin Sodium Copper (64Cu) Chloride TROFOLASTAT Litenimod Sodium Donepezil D5-Ethyl-Beta-D-Glucuronide Histamine Hydrochloride Radium Ra 223 Dichloride Pralsetinib GS-1720 AUR200 Gskvx000000008866 Istaroxime Tremelimumab GEN1078 Atazanavir Lacnotuzumab Salbutamol Pegaspargase More therapies…

    Learn about Your Condition

    Heart disease congenital Hereditary ataxia Rhabdoid tumour Ovarian cancer stage IV Sarcoma Chorioretinitis Squamous cell carcinoma Diabetic gastroparesis Parkinson's disease Anaemia of pregnancy T-cell type acute leukaemia Mitral valve disease Perinatal depression Hepatobiliary cancer Alcoholic liver disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Vericiguat for Children with Heart Failure from Left Ventricular Systolic Dysfunction

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure
    • Left ventricular dysfunction
    Investigated Drugs:
    • Vericiguat
    Belgium Denmark Finland France Germany Hungary +7

  • Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Budesonide
    • Dexpramipexole Dihydrochloride Monohydrate
    • Formoterol Fumarate Dihydrate
    Austria Croatia Czechia France Germany Hungary +3

  • Study on the Effects of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) in Patients with Progressive Supranuclear Palsy

    Not recruiting

    3 1
    Investigated Drugs:
    • Phenylbutyrate
    • Ursodoxicoltaurine
    Austria Belgium Bulgaria France Germany Italy +4

  • Study on Oral PHA-022121 for Preventing Angioedema Attacks in Patients with Hereditary Angioedema

    Not recruiting

    2 1
    Investigated Diseases:
    • Hereditary angioedema
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • (S)-N-(1-Deutero-1-(3-Chloro-5-Fluoro-2-((2-Methyl-4-(1-Methyl-1H-1,2,4-Triazol-5-Yl)Quinolin-8-Yloxy)Methyl)Phenyl)Ethyl)-2-(Difluoromethoxy)Acetamide
    Austria Bulgaria Germany Ireland Italy Poland

  • Study on the Effectiveness and Safety of Fluticasone Propionate and Salbutamol Sulfate for Patients with Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Asthma
    Investigated Drugs:
    • Salbutamol Sulfate
    • Fluticasone Propionate
    Bulgaria Czechia Denmark Germany Greece Hungary +6

  • Study on the Effectiveness and Safety of Obinutuzumab for Patients with Systemic Lupus Erythematosus

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Obinutuzumab
    Czechia France Italy Poland Spain

  • Study of Oral Ozanimod as Maintenance Treatment for Adults with Moderate to Severe Crohn’s Disease

    Not recruiting

    3 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ozanimod
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study on ALXN1850 for Adolescents and Adults with Hypophosphatasia Not Previously Treated with Asfotase Alfa

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypophosphatasia
    Investigated Drugs:
    • Alxn1850
    Austria Belgium France Germany Italy Poland +2

  • Study on the Effects of VH4524184 for Adults Newly Diagnosed with HIV

    Not recruiting

    2 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Vh4524184
    Italy Spain

  • Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Zibotentan
    • Dapagliflozin
    Belgium Czechia Germany Italy Poland Slovakia
Previous Page
1 … 30 31 32 33 34 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!